Critical Reviews in Clinical Laboratory Sciences

Papers
(The H4-Index of Critical Reviews in Clinical Laboratory Sciences is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The anion gap as a predictive tool for morbidity and mortality61
Deep learning algorithms and Raman spectroscopy in the clinical laboratory setting57
The dual roles of microorganisms in inflammatory diseases: initiators and regulators49
Machine learning-based error detection in the clinical laboratory: a critical review47
Data analytics for error detection in clinical laboratories43
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease35
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review34
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application33
Transthyretin mutagenesis: impact on amyloidogenesis and disease32
Single cell mechanodeformation signatures as early biomarkers for hematological malignancies31
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications27
Clinical utility of human epididymis protein 425
Comparison of liquid biopsy-based technologies for cancer screening24
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology24
Cardiovascular disease lipids and lipoproteins biomarker standardization23
Beyond newborn screening: the role of reverse cascade testing in familial disease detection23
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation21
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker21
One health and laboratory medicine: challenges and perspectives for antimicrobial resistance, emerging infections, and food/water security21
Mid-regional pro-atrial natriuretic peptide in managing cardiovascular and cerebrovascular diseases20
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration20
0.26976585388184